WELLINGTON MANAGEMENT GROUP LLP

Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

Symbol
CRNX on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Shares Owned
8,381,991 shares
Security Ownership %
8.9%
Shares, Excluding Options vs Price
Value, Excluding Options

Wellington Management Group LLP ownership in Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX)

12 Nov 2025 - Wellington Management Group LLP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,381,991 shares of Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX). This represents 8.9% ownership of the company. In their previous filing dated 12 Aug 2025, WELLINGTON MANAGEMENT GROUP LLP had reported owning 5,807,308 shares, indicating an increase of +44%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.